设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 10 期 第 16 卷

子宫内膜癌合并冠心病患者手术安全性和可行性的临床分析

Clinical analysis of surgical safety and practicability in patients with endometrial carcinoma complicated with coronary atherosclerotic heart disease

作者:褚黎1张军1于楚瑶2沈君泽2邱宇晨2吴璇2

英文作者:Chu Li1 Zhang Jun1 Yu Chuyao2 Shen Junze2 Qiu Yuchen2 Wu Xuan2

单位:1首都医科大学附属北京安贞医院妇产科100029;2首都医科大学第六临床医学院,北京100029

英文单位:1Department of Obstetrics and Gynecology Beijing Anzhen Hospital Capital Medical University Beijing 100029 China; 2Sixth Clinical Medical College Capital Medical University Beijing 100029 China

关键词:子宫内膜癌;冠心病(冠状动脉粥样硬化性心脏病);手术;安全性

英文关键词:Endometrialcarcinoma;Coronaryatheroscleroticheartdisease;Operation;Safety

  • 摘要:
  • 目的  探讨子宫内膜癌合并冠心病(冠状动脉粥样硬化性心脏病)患者的手术安全性和可行性。方法 回顾性分析20141月至201912月首都医科大学附属北京安贞医院收治的90例子宫内膜癌行手术治疗的患者的临床资料。根据是否合并冠心病,将患者分为冠心病组(子宫内膜癌合并冠心病的患者,32例)和无冠心病组(单纯子宫内膜癌患者,58例)。随访至202012月,对2组患者的术中术后临床指标、复发及死亡情况进行统计分析。结果 冠心病组和无冠心病组患者年龄、体重指数、肿瘤组织类型、分化程度等级、国际妇产科联盟分类类型方面差异均无统计学意义(均P>0.05)。冠心病组9例行开腹手术、23例行腹腔镜手术,无冠心病组9例行开腹手术、49例行腹腔镜手术。2组患者手术病理分期、出血量、发热比例、手术入路、不同部位淋巴结阳性比例差异均无统计学意义(均P>0.05)。术后至随访截止,冠心病组和无冠心病组患者复发率、病死率差异均无统计学意义[15.6%5/32)比6.9%4/58)、15.6%5/32)比8.6%5/58)](χ2=1.641P=0.200 χ2<0.001P=0.993)。Log-rank检验结果 显示,2组患者复发时间和死亡时间差异均无统计学意义(χ2=0.960P=0.327 χ2=0.296P=0.586)。结论 子宫内膜癌合并冠心病的患者手术治疗安全可行,有利于提高患者的生存率。

  • Objective To investigate the surgical safety and practicability in patients with endometrial carcinoma complicated with coronary atherosclerotic heart disease (CHD). Methods The clinical data of 90 patients with endometrial carcinoma who underwent surgery in Beijing Anzhen Hospital, Capital Medical University from January 2014 to December 2019 were retrospectively analyzed. The patients were divided into CHD group(endometrial carcinoma complicated with CHD, 32 cases) and non CHD group(endometrial carcinoma alone, 58 cases). All patients were followed-up to December 2020, and the intraoperative and postoperative clinical indexes, recurrence and mortality of the two groups were statistically analyzed. Results There were no significant differences in age, body mass index, tumor tissue type, grade of differentiation, International Federation of Gynecology and Obstetrics classification between the two groups(all P>0.05). In CHD group, 9 cases underwent open surgery and 23 cases underwent laparoscopic surgery; in non CHD group, 9 cases underwent open surgery and 49 cases underwent laparoscopic surgery. There were no significant differences in operative pathological stage, blood loss, fever rate, operative approach and positive rate of lymph nodes in different parts between the two groups(all P>0.05). From the end of operation to the end of follow-up, there were no significant differences in recurrent rate and mortality between CHD group and non CHD group15.6%(5/32) vs 6.9%(4/58), 15.6%(5/32) vs 8.6%(5/58)](χ2=1.641, P=0.200; χ2<0.001, P=0.993. Log-rank test showed that there were no significant differences in recurrent time and death time between the two groups(χ2=0.960, P=0.327; χ2=0.296, P=0.586. Conclusion Operation is safe and feasible in patients with endometrial carcinoma complicated with CHD, which is beneficial to improve the survival rate of the patients.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭